Retraction
SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment
Paper Information
Record ID:
62911
Journal:
Publication Date:
January 11, 2016
Retraction Date:
November 19, 2024
(1.0 year years ago)
Subjects:
Institutions:
- Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS) and Shanghai Jiaotong University School of Medicine (SJTUSM), Shanghai, China
- Collaborative Innovation Center of Systems Biomedicine, Shanghai Jiaotong University School of Medicine, Shanghai, China
- Department of Medicine and VAPSHCS, University of Washington, Seattle, WA, USA
- Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
- Department of Pharmacology, Changzheng Hospital, Second Military Medical University, Shanghai, China
Countries:
Article Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (108)
108
Total Citations5
Post-Retraction(4.6%)
103
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
5
Within 1 year
0
After 2+ years
177
Days since retraction (latest)
Tumor budding and poorly differentiated clusters as a biological continuum in colorectal cancer invasion and prognosis
Tariq Sami Haddad, John‐Melle Bokhorst, Luuk van den Dobbelsteen et al. (20 authors)
Scientific Reports
Open Access
Published: May 2025
177 days after retraction
Targeting Senescence with Apigenin Improves Chemotherapeutic Efficacy and Ameliorates Age‐Related Conditions in Mice
Hongwei Zhang, Qixia Xu, Zhirui Jiang et al. (11 authors)
Advanced Science
Open Access
Published: Apr 2025
155 days after retraction
Single-cell and bulk RNA-sequence identify an immune-derived lncRNA-mRNA signature for predicting clinical outcomes and immunotherapeutic response of prostate cancer
Ren Liu, Hiocheng Un, Renxuan Lin et al. (11 authors)
International Journal of Biological Macromolecules
Open Access
Published: Apr 2025
133 days after retraction
FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity
Rongyuan Wei, Junquan Song, Chenchen Liu et al. (11 authors)
Cancer Letters
Published: Jan 2025
5 citations
5 citations
43 days after retraction
WNT16 Primer
McLean Williamson, Wilson K. Clements
Differentiation
Published: Dec 2024
12 days after retraction
SFRP2 modulates functional phenotype transition and energy metabolism of macrophages during diabetic wound healing
Jiaqi Yang, Guoying Xiong, Huijuan He et al. (4 authors)
Frontiers in Immunology
Open Access
Published: Oct 2024
3 citations
3 citations
39 days before retraction
Comparative transcriptome of normal and cancer-associated fibroblasts
Apoorva Abikar, Mohammad Mehaboob Subhani Mustafa, Radhika Rajiv Athalye et al. (8 authors)
BMC Cancer
Open Access
Published: Oct 2024
2 citations
2 citations
45 days before retraction
Repurposing the plant-derived compound apigenin for senomorphic effect in antiaging pipelines
Hongwei Zhang, Qixia Xu, Zhirui Jiang et al. (8 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2024
70 days before retraction
Comprehensive summary: the role of PBX1 in development and cancers
Mingsheng Liu, Xing Yan, Jiufeng Tan et al. (8 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Jul 2024
1 citation
1 citation
116 days before retraction
Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
Birong Jiang, Wei Zhang, Xuguang Zhang et al. (4 authors)
Seminars in Cancer Biology
Open Access
Published: May 2024
10 citations
10 citations
176 days before retraction
Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation
Fuchao Li, Lei Liu, Qingzhao Feng et al. (10 authors)
World Journal of Surgical Oncology
Open Access
Published: Apr 2024
2 citations
2 citations
211 days before retraction
Investigating the Role of SNAI1 and ZEB1 Expression in Prostate Cancer Progression and Immune Modulation of the Tumor Microenvironment
William Lautert-Dutra, Camila Morais Melo, Luiz Paulo Chaves et al. (12 authors)
Cancers
Open Access
Published: Apr 2024
4 citations
4 citations
221 days before retraction
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL)
Hayley J Hawkins, Betelehem W. Yacob, Monica E. Brown et al. (16 authors)
PLoS ONE
Open Access
Published: Apr 2024
6 citations
6 citations
223 days before retraction
Prediction of metastatic and recurrence in prostate cancer patients based on BMP-related differential gene indicators in prostate cancer bone metastases
Ju Qiu, Jianpeng Hu
Research Square (Research Square)
Open Access
Published: Apr 2024
230 days before retraction
Comparative transcriptome of normal and cancer- associated fibroblasts
Apoorva Abikar, Mohammad Mehaboob Subhani Mustafa, Radhika Rajiv Athalye et al. (8 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2024
244 days before retraction
High-accuracy prediction of colorectal cancer chemotherapy efficacy using machine learning applied to gene expression data
Soukaina Amniouel, M. Saleet Jafri
Frontiers in Physiology
Open Access
Published: Jan 2024
8 citations
8 citations
306 days before retraction
Sfrp2 promotes renal dysfunction of diabetic kidney disease via modulating Fzd5-induced cytosolic calcium ion concentration and CaMKII/Mek/Erk pathway in mesangial cells
Dan Lv, Ziyue Lin, Xiao-Hui Liao et al. (9 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Published: Nov 2023
4 citations
4 citations
375 days before retraction
Secreted frizzled related-protein 2 is prognostic for human pancreatic cancer patient survival and is associated with fibrosis
Julie B. Siegel, Patrick Nasarre, Lillian Y. F. Hsu et al. (14 authors)
Cancer Biomarkers
Open Access
Published: Nov 2023
378 days before retraction
Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence
William Lautert-Dutra, Camila Morais Melo, Luiz Paulo Chaves et al. (12 authors)
Frontiers in Oncology
Open Access
Published: Oct 2023
3 citations
3 citations
390 days before retraction
Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer
Nelleke P.M. Brouwer, Loth Webbink, Tariq Sami Haddad et al. (16 authors)
The Journal of Pathology
Open Access
Published: Oct 2023
14 citations
14 citations
412 days before retraction
Engineered bone marrow as a clinically relevant ex vivo model for primary bone cancer research and drug screening
Katherine H. Griffin, Steven W. Thorpe, Aimy Sebastian et al. (9 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Sep 2023
7 citations
7 citations
426 days before retraction
Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy
Hanxin Liu, Qixia Xu, Halidan Wufuer et al. (10 authors)
Aging Cell
Open Access
Published: Jul 2023
80 citations
80 citations
488 days before retraction
IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
Jian Liao, Qing-hong Qin, Fa-you Lv et al. (8 authors)
Scientific Reports
Open Access
Published: Apr 2023
4 citations
4 citations
582 days before retraction
Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer
Wei Bin Fang, Marcela Medrano, Paige Cote et al. (11 authors)
Frontiers in Oncology
Open Access
Published: Apr 2023
5 citations
5 citations
593 days before retraction
Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line
McKaela Hodge, Tasha Miller, Marcus A. Weinman et al. (6 authors)
Genes
Open Access
Published: Feb 2023
1 citation
1 citation
635 days before retraction
Advances of Wnt Signalling Pathway in Colorectal Cancer
Yaoyao Zhu, Xia Li
Cells
Open Access
Published: Jan 2023
62 citations
62 citations
659 days before retraction
IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
Jian Liao, Qing-hong Qin, Fa-you Lv et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Jan 2023
673 days before retraction
An in-depth study of DOPE:DOPC liposomes to maximize targeted drug delivery to cancer-associated cells
Tanzeel Ur Rehman
Unknown Journal
Open Access
Published: Jan 2023
688 days before retraction
IL-27 deficiency inhibits proliferation and invasion of trophoblasts via the SFRP2/Wnt/β-catenin pathway in fetal growth restriction
Xinyan Zhang, Xueyun Qin, Hui‐Hui Shen et al. (9 authors)
International Journal of Medical Sciences
Open Access
Published: Jan 2023
5 citations
5 citations
688 days before retraction
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer
Dimitrios Makrakis, Jonathan L. Wright, Martine P. Roudier et al. (21 authors)
Clinical Genitourinary Cancer
Published: Dec 2022
7 citations
7 citations
697 days before retraction
SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells
Elif Akova, Attila Aszódi, Hanna Taipaleenmäki et al. (9 authors)
Cells
Open Access
Published: Dec 2022
11 citations
11 citations
704 days before retraction
Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice
Jing Zhao, Sungwook Jung, Xiaofei Li et al. (21 authors)
Journal of Clinical Investigation
Open Access
Published: Dec 2022
19 citations
19 citations
706 days before retraction
Drug Resistance and Its Clinical Circumvention
Jeffrey A. Moscow, Shannon K. Hughes, Kenneth H. Cowan et al. (4 authors)
Holland‐Frei Cancer Medicine
Published: Oct 2022
6 citations
6 citations
760 days before retraction
Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance
Changxu Wang, Qilai Long, Qiang Fu et al. (12 authors)
Oncogene
Open Access
Published: Oct 2022
19 citations
19 citations
775 days before retraction
Exploring the role of senescence inducers and senotherapeutics as targets for anticancer natural products
Abdullah Al Mamun, Mohammad Abu Sufian, Md. Sahab Uddin et al. (9 authors)
European Journal of Pharmacology
Published: May 2022
22 citations
22 citations
932 days before retraction
Bête Noire of Chemotherapy and Targeted Therapy: CAF-Mediated Resistance
Pradip De, Jennifer C. Aske, Raed Sulaiman et al. (4 authors)
Cancers
Open Access
Published: Mar 2022
18 citations
18 citations
979 days before retraction
The Case for Cancer-Associated Fibroblasts: Essential Elements in Cancer Drug Discovery?
Gabrielle Brewer, Anne-Marie Fortier, Morag Park et al. (4 authors)
Future Drug Discovery
Open Access
Published: Mar 2022
4 citations
4 citations
994 days before retraction
Langerhans cells and SFRP2/Wnt/beta‐catenin signalling control adaptation of skin epidermis to mechanical stretching
Joanna K. Ledwon, Elbert E. Vaca, Chiang Ching Huang et al. (8 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Jan 2022
17 citations
17 citations
1042 days before retraction
Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
Hanxin Liu, Huifang Zhao, Yu Sun
Seminars in Cancer Biology
Open Access
Published: Nov 2021
73 citations
73 citations
1099 days before retraction
Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells
Ying Zhang, Qiuzi Liu, Wei Wei et al. (12 authors)
BMC Cancer
Open Access
Published: Oct 2021
9 citations
9 citations
1133 days before retraction
The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance
Bikash Chandra Jena, Siddik Sarkar, Lipsa Rout et al. (4 authors)
Cancer Letters
Published: Aug 2021
80 citations
80 citations
1202 days before retraction
Improving selective targeting to cancer-associated fibroblasts by modifying liposomes with arginine based materials
Tanzeel Ur Rehman, Kaitlin M. Bratlie
Journal of drug targeting
Published: Jun 2021
1 citation
1 citation
1256 days before retraction
Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma
Patrick Nasarre, Denise I. Garcia, Julie B. Siegel et al. (13 authors)
Cancers
Open Access
Published: May 2021
7 citations
7 citations
1269 days before retraction
SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma
Min Guo, Kaveh M. Goudarzi, Shiva Abedi et al. (12 authors)
Oncogene
Open Access
Published: May 2021
20 citations
20 citations
1278 days before retraction
KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
Luca Járomi, Veronika Csöngei, Monika Vesel et al. (9 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2021
14 citations
14 citations
1279 days before retraction
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy
Nicholas C. DeVito, Michael Sturdivant, Balamayooran Thievanthiran et al. (11 authors)
Cell Reports
Open Access
Published: May 2021
67 citations
67 citations
1298 days before retraction
Possibility of inducing tumor cell senescence during therapy (Review)
Guohui Wang, Xianliang Cheng, Jingyi Zhang et al. (6 authors)
Oncology Letters
Open Access
Published: Apr 2021
11 citations
11 citations
1302 days before retraction
Glycyrrhetinic acid remodels the tumor microenvironment and synergizes with doxorubicin for breast cancer treatment in a murine model
Mingxiu Tang, Mengjia Yang, Kaiyong He et al. (8 authors)
Nanotechnology
Published: Jan 2021
5 citations
5 citations
1392 days before retraction
Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer
Ryoichi Katsube, Kazuhiro Noma, Toshiaki Ohara et al. (15 authors)
Scientific Reports
Open Access
Published: Jan 2021
70 citations
70 citations
1401 days before retraction
The Clinical Significance of DNA Damage Repair Signatures in Clear Cell Renal Cell Carcinoma
Ergang Guo, Cheng Wu, Jun Ming et al. (6 authors)
Frontiers in Genetics
Open Access
Published: Jan 2021
12 citations
12 citations
1411 days before retraction
Quick Stats
Total Citations:
108
Years Since Retraction:
1.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025